The Drug-Induced Respiratory Disease Website and App
Frequency - Incidence
Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases
Evidence level/grade
Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic
Pulmonary embolism - Venous thrombosis/thromboembolism
Publications
Acute massıve pulmonary embolism assocıated wıth olanzapıne.
The American journal of emergency medicine. 2017;35(10):1582.e5-1582.e7
Pulmonary thromboembolism associated with olanzapine treatment.
Chinese medical journal. 2015;128(3):419-20
Acute massive pulmonary embolism associated with olanzapine therapy and no significant personal history in a young male--case report and literature review.
Pneumologia (Bucharest, Romania). 2011;60(2):82-4
Olanzapine: a new risk factor for pulmonary embolus?
The American journal of forensic medicine and pathology. 2008;29(4):368-70
Pulmonary thromboembolism associated with olanzapine and risperidone.
The Journal of emergency medicine. 2008;35(2):159-61
Pulmonary embolism possibly associated with olanzapine treatment.
BMJ (Clinical research ed.). 2003;327(7428):1384
[Treatment of retinal detachment by silicone implant and banding. First results in 199 records analyzed by computer].
Bulletin des societes d'ophtalmologie de France. 1984;84(2):165-9